More flexible CMS vaccine mandate enforcement cheers providers … Higher vitality means healthier residents, more productive workforce: report … SNFs under the microscope again on readmissions … HHS:...
Clinical briefs for Wednesday, Aug. 17
By
Alicia Lasek
Aug 17, 2022
Makers of new class of schizophrenia drug expect to file for FDA approval … Precancerous skin lesions common among Medicare beneficiaries: study … Triple therapy halves mortality in patients with severe...
Soaring dementia treatment costs leave care providers to find solutions: report
By
Alicia Lasek
Nov 02, 2022
The growing needs of patients will put the onus on healthcare providers and other stakeholders to increase access to high-quality dementia care services, the Milken Institute reports.
Antibiotic overkill leads to widespread side effects such as C. diff, large study finds
By
Alicia Lasek
Apr 02, 2023
“We’re talking about hundreds of thousands of adverse events severe enough that these patients needed additional care from a doctor,” an investigator said.
Treatment patterns, not genetics, drive prostate cancer disparities, study finds
By
Alicia Lasek
May 29, 2023
Prostate cancer, which affects 1 in 11 men aged 70 and older, has some of the largest disparities in outcomes across all cancer types, investigators say.
Study: When community-onset SARS-CoV-2 went up, so did cases that started in hospitals
By
Kristen Fischer
Aug 29, 2023
Rates of people contracting SARS-CoV-2 in the hospital were similar to other hospital-acquired infections. But when the number of infections that began in the community was higher, there was an increase...
On eve of Alzheimer’s drug decision, Congress critiques FDA for Aduhelm review failures
By
Alicia Lasek
Jan 03, 2023
An “atypical review process and corporate greed” factored into the FDA’s approval of Alzheimer’s drug Aduhelm in 2021, congressional investigators say. They recommend sticking to protocol...
Nursing home providers help to design, refine facility IP program
By
Alicia Lasek
Apr 26, 2023
In partnership with providers, an infection control peer coaching program has been updated to improve its utility amid competing facility priorities and staffing shortages.
Depression drug eases Alzheimer’s agitation; new death in lecanemab trial raises concerns
By
Alicia Lasek
Nov 30, 2022
Two drugs in late-stage clinical trials are making news, one as a potential treatment for agitation, and the other for evidence of bleeding risk.
Cognitive skills decline with age, but the brain may compensate, study finds
By
Alicia Lasek
Sep 19, 2022
As it ages, the brain may attempt to make up for decline in some areas while it loses function elsewhere, investigators report.